Compare Two Different Fractionated Regimes of HDR Intracavitary Brachytherapy after Concomitant Chemoradiation in Carcinoma Cervix: A Prospective Study
Background: Cervical cancer is the common cancer cause of death among women in developing countries. High Dose Rate (HDR) intracavitary brachytherapy that is given with or sequential after EBRT, is an integral component in the treatment of carcinoma of the cervix. In recent years, High Dose Rate (HD...
Main Authors: | Mayur Khandelwal, Divya Sharma, Anjali T, Shankar Lal Jakhar |
---|---|
Format: | Article |
Language: | English |
Published: |
West Asia Organization for Cancer Prevention
2024-01-01
|
Series: | Asian Pacific Journal of Cancer Care |
Subjects: | |
Online Access: | http://www.waocp.com/journal/index.php/apjcc/article/view/1176 |
Similar Items
-
Concomitant chemoradiotherapy, brachytherapy, and parametrial boost versus concomitant chemoradiation and brachytherapy alone in locally advanced cervical carcinoma: A prospective and comparative study
by: Saptarshi Banerjee, et al.
Published: (2023-04-01) -
Treatment outcomes of concurrent weekly cisplatin with intracavitary brachytherapy in patients with cervical carcinoma, pre-treated with concurrent chemo-radiotherapy
by: Swapan K Mallick, et al.
Published: (2022-01-01) -
The Relationship Between Late Morbidity and Dose–Volume Parameter of Rectum in Combined Intracavitary/Interstitial Cervix Cancer Brachytherapy: A Mono-Institutional Experience
by: Ning Zhang, et al.
Published: (2021-07-01) -
Estimating the accumulative dose uncertainty for intracavitary and interstitial brachytherapy
by: Binbing Wang, et al.
Published: (2021-10-01) -
Comparison of two high dose rate intracavitary brachytherapy regimens in treatment of cervical cancer: a preliminary report
by: Abhishek Krishna, et al.
Published: (2023-03-01)